Lanean...
A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancer
PURPOSE: Germ cell tumors (GCTs) are cured with therapy based on cisplatin, although a clinically significant number of patients are refractory and die of progressive disease. Based on preclinical studies indicating that refractory testicular GCTs are hypersensitive to hypomethylating agents (HMAs),...
Gorde:
| Argitaratua izan da: | Cancer Med |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7826483/ https://ncbi.nlm.nih.gov/pubmed/33135391 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3583 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|